Search research articles
Contact Us
Filters
Showing results (41-50 of 139) with videos related to
Page
of 14
Sort By:
Clinical Proteomics
|
May 15, 2022
Optimized sample preparation and data analysis for TMT proteomic analysis of cerebrospinal fluid applied to the identification of Alzheimer's disease biomarkers
Sophia Weiner, Mathias Sauer, Pieter Jelle Visser, et al.
Clinical Proteomics
|
February 15, 2026
Shake and bake: a robust and cost-effective proteomic sample preparation workflow for plasma and cerebrospinal fluid
John Rönnholm, Sophia Weiner, Johannes Fuchs, et al.
Fluids and Barriers of the CNS
|
March 3, 2025
Applying machine learning to high-dimensional proteomics datasets for the identification of Alzheimer's disease biomarkers
Christoffer Ivarsson Orrelid, Oscar Rosberg, Sophia Weiner, et al.
Journal of Visualized Experiments : Jove
|
December 30, 2017
Sample Preparation for Endopeptidomic Analysis in Human Cerebrospinal Fluid
Karl T Hansson, Tobias Skillbäck, Elin Pernevik, et al.
Journal of Neuroinflammation
|
July 27, 2018
Levels of ADAM10 are reduced in Alzheimer's disease CSF
Aitana Sogorb-Esteve, María-Salud García-Ayllón, Johan Gobom, et al.
Journal of Alzheimer'S Disease : JAD
|
September 17, 2016
Comprehensive Quantitative Profiling of Tau and Phosphorylated Tau Peptides in Cerebrospinal Fluid by Mass Spectrometry Provides New Biomarker Candidates
Claire L Russell, Vikram Mitra, Karl Hansson, et al.
BMC Bioinformatics
|
December 2, 2005
Transformation and other factors of the peptide mass spectrometry pairwise peak-list comparison process
Witold E Wolski, Maciej Lalowski, Peter Martus, et al.
Journal of Neurology
|
November 2, 2023
Differential patterns of lysosomal dysfunction are seen in the clinicopathological forms of primary progressive aphasia
Imogen J Swift, Simon Sjödin, Johan Gobom, et al.
Brain Research
|
September 30, 2010
Neurogranin in cerebrospinal fluid as a marker of synaptic degeneration in Alzheimer's disease
Annika Thorsell, Maria Bjerke, Johan Gobom, et al.
The Journal of Biological Chemistry
|
November 1, 2005
Analysis of NOD2-mediated proteome response to muramyl dipeptide in HEK293 cells
Dieter Weichart, Johan Gobom, Sina Klopfleisch, et al.
Page
of 14
Search research articles
Search
Showing results (41-50 of 139) with videos related to
Sort By:
Page
of 14
Clinical Proteomics
|
May 15, 2022
Optimized sample preparation and data analysis for TMT proteomic analysis of cerebrospinal fluid applied to the identification of Alzheimer's disease biomarkers
Sophia Weiner, Mathias Sauer, Pieter Jelle Visser, et al.
Clinical Proteomics
|
February 15, 2026
Shake and bake: a robust and cost-effective proteomic sample preparation workflow for plasma and cerebrospinal fluid
John Rönnholm, Sophia Weiner, Johannes Fuchs, et al.
Fluids and Barriers of the CNS
|
March 3, 2025
Applying machine learning to high-dimensional proteomics datasets for the identification of Alzheimer's disease biomarkers
Christoffer Ivarsson Orrelid, Oscar Rosberg, Sophia Weiner, et al.
Journal of Visualized Experiments : Jove
|
December 30, 2017
Sample Preparation for Endopeptidomic Analysis in Human Cerebrospinal Fluid
Karl T Hansson, Tobias Skillbäck, Elin Pernevik, et al.
Journal of Neuroinflammation
|
July 27, 2018
Levels of ADAM10 are reduced in Alzheimer's disease CSF
Aitana Sogorb-Esteve, María-Salud García-Ayllón, Johan Gobom, et al.
Journal of Alzheimer'S Disease : JAD
|
September 17, 2016
Comprehensive Quantitative Profiling of Tau and Phosphorylated Tau Peptides in Cerebrospinal Fluid by Mass Spectrometry Provides New Biomarker Candidates
Claire L Russell, Vikram Mitra, Karl Hansson, et al.
BMC Bioinformatics
|
December 2, 2005
Transformation and other factors of the peptide mass spectrometry pairwise peak-list comparison process
Witold E Wolski, Maciej Lalowski, Peter Martus, et al.
Journal of Neurology
|
November 2, 2023
Differential patterns of lysosomal dysfunction are seen in the clinicopathological forms of primary progressive aphasia
Imogen J Swift, Simon Sjödin, Johan Gobom, et al.
Brain Research
|
September 30, 2010
Neurogranin in cerebrospinal fluid as a marker of synaptic degeneration in Alzheimer's disease
Annika Thorsell, Maria Bjerke, Johan Gobom, et al.
The Journal of Biological Chemistry
|
November 1, 2005
Analysis of NOD2-mediated proteome response to muramyl dipeptide in HEK293 cells
Dieter Weichart, Johan Gobom, Sina Klopfleisch, et al.
Page
of 14